AbbVie (ABBV) Maintains Dividend Strength as Core Drugs Drive Cash Flow
Summary
AbbVie Inc. (NYSE:ABBV) is a global biopharma company built around research and a fairly broad mix of treatments.
Description
AbbVie Inc. (NYSE:ABBV) is a global biopharma company built around research and a fairly broad mix of treatments.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source